Nutrien (NYSE:NTR) PT Raised to $59.00

Nutrien (NYSE:NTR - Get Free Report) had its target price lifted by equities researchers at Mizuho from $54.00 to $59.00 in a research note issued on Thursday, Benzinga reports. The firm currently has a "neutral" rating on the stock. Mizuho's price target would indicate a potential upside of 1.43% from the company's current price.

Several other research firms have also weighed in on NTR. Wells Fargo & Company reduced their price target on shares of Nutrien from $77.00 to $69.00 and set an "overweight" rating for the company in a research report on Monday, February 26th. HSBC reduced their price objective on Nutrien from $63.00 to $57.00 and set a "hold" rating for the company in a report on Friday, March 8th. Berenberg Bank upgraded Nutrien from a "hold" rating to a "buy" rating and boosted their target price for the company from $60.00 to $66.00 in a research note on Monday, April 29th. Stifel Nicolaus lifted their price objective on Nutrien from $72.00 to $75.00 and gave the stock a "buy" rating in a report on Friday, January 19th. Finally, CIBC dropped their price objective on shares of Nutrien from $87.00 to $76.00 and set an "outperform" rating on the stock in a report on Friday, February 23rd. Two research analysts have rated the stock with a sell rating, five have assigned a hold rating and twelve have issued a buy rating to the company's stock. According to data from MarketBeat.com, Nutrien has an average rating of "Moderate Buy" and an average price target of $67.50.

Nutrien Trading Up 4.9 %

Shares of NTR stock traded up $2.74 on Thursday, hitting $58.17. The company had a trading volume of 3,271,652 shares, compared to its average volume of 1,972,914. The stock's 50-day moving average is $53.44 and its two-hundred day moving average is $53.63. Nutrien has a twelve month low of $47.90 and a twelve month high of $69.12. The firm has a market cap of $28.77 billion, a P/E ratio of 22.99, a P/E/G ratio of 1.98 and a beta of 0.89. The company has a debt-to-equity ratio of 0.35, a quick ratio of 0.65 and a current ratio of 1.17.

Nutrien (NYSE:NTR - Get Free Report) last issued its quarterly earnings results on Wednesday, February 21st. The company reported $0.37 EPS for the quarter, missing analysts' consensus estimates of $0.72 by ($0.35). The firm had revenue of $5.66 billion for the quarter, compared to the consensus estimate of $5.36 billion. Nutrien had a net margin of 4.33% and a return on equity of 8.59%. The business's revenue was down 24.8% compared to the same quarter last year. During the same period last year, the company posted $2.02 EPS. On average, equities research analysts anticipate that Nutrien will post 3.82 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Nutrien

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the company. GoalVest Advisory LLC bought a new stake in Nutrien in the first quarter worth $35,000. Exchange Traded Concepts LLC boosted its stake in shares of Nutrien by 904.0% during the 4th quarter. Exchange Traded Concepts LLC now owns 753 shares of the company's stock worth $42,000 after purchasing an additional 678 shares during the period. Evolution Advisers Inc. bought a new position in Nutrien during the 4th quarter valued at about $49,000. NBC Securities Inc. purchased a new stake in Nutrien in the 3rd quarter worth about $58,000. Finally, Andra AP fonden bought a new stake in Nutrien in the third quarter worth about $62,000. Institutional investors own 63.10% of the company's stock.

About Nutrien

Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.